Endoscopic submucosal dissection (ESD) represents a significant advance in therapeutic endoscopy with the major advantage being the ability to achieve a higher en bloc resection rate for early stage ...

Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are commonly used for the minimally invasive treatment of submucosal lesions of the gastrointestinal tract. To evaluate ...

The endoscopic submucosal dissection (ESD) market is expanding at a steady CAGR of ~6%, driven by the increasing prevalence of gastrointestinal cancers and a growing preference for minimally invasive ...

Additionally, the publication of clinical guidelines by leading gastroenterological societies in Western countries has legitimized the use of ESD for treating early-stage gastric, esophageal, and ...

Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...

The endoscopic submucosal dissection (ESD) market is expanding at a steady CAGR of ~6%, driven by the increasing prevalence of gastrointestinal cancers and a growing preference for minimally invasive ...

A prospective clinical trial from researchers in Japan shows magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer to be a feasible and safe method in humans.

New York, United States, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Global Endoscopic Submucosal Dissection Market Size is expected to reach USD 542.38 Million By 2032, at a CAGR of 5.4% during the ...

The evidence on efficacy of endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) of non-ampullary duodenal lesions is limited in quantity and there are safety concerns ...

Although highly experienced Japanese endoscopists have proven that they can perform CR-ESD safely and effectively, it should be remembered that successful endoscopy procedures depend on the skillful ...